| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | protein serine kinase activity | STK35 CDC42BPB CDK10 ULK3 MAP3K10 TAOK1 PKN2 DCLK2 MAPK7 MAP3K21 DCLK1 | 7.45e-06 | 363 | 114 | 11 | GO:0106310 |
| GeneOntologyMolecularFunction | protein kinase activity | STK35 CDC42BPB CDK10 SCYL2 ULK3 MST1R BRD4 MAP3K10 TAOK1 PKN2 DCLK2 MAPK7 MAP3K21 DCLK1 | 8.29e-06 | 600 | 114 | 14 | GO:0004672 |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | STK35 CDC42BPB CDK10 ULK3 BRD4 MAP3K10 TAOK1 PKN2 DCLK2 MAPK7 MAP3K21 DCLK1 | 9.39e-06 | 446 | 114 | 12 | GO:0004674 |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | STK35 CDC42BPB CDK10 SCYL2 ULK3 MST1R BRD4 MAP3K10 TAOK1 PKN2 DCLK2 MAPK7 MAP3K21 DCLK1 | 5.24e-05 | 709 | 114 | 14 | GO:0016773 |
| GeneOntologyMolecularFunction | kinase activity | STK35 CDC42BPB CDK10 SCYL2 ULK3 MST1R BRD4 MAP3K10 TAOK1 PKN2 DCLK2 MAPK7 MAP3K21 DCLK1 | 1.16e-04 | 764 | 114 | 14 | GO:0016301 |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | STK35 CDC42BPB CDK10 POLR3A SCYL2 ULK3 MST1R BRD4 MAP3K10 TAOK1 PKN2 DCLK2 MAPK7 MAP3K21 DCLK1 | 2.88e-04 | 938 | 114 | 15 | GO:0016772 |
| GeneOntologyMolecularFunction | DNA translocase activity | 3.19e-04 | 5 | 114 | 2 | GO:0015616 | |
| GeneOntologyMolecularFunction | piRNA binding | 4.77e-04 | 6 | 114 | 2 | GO:0034584 | |
| GeneOntologyBiologicalProcess | meiotic cell cycle process | NCAPD3 EME1 HUS1 PIWIL2 PSMD13 FANCD2 ZSCAN21 WASHC5 MOV10L1 RAD54B RAD54L | 3.13e-07 | 268 | 115 | 11 | GO:1903046 |
| GeneOntologyBiologicalProcess | meiotic nuclear division | NCAPD3 EME1 PIWIL2 PSMD13 FANCD2 ZSCAN21 WASHC5 MOV10L1 RAD54B RAD54L | 9.66e-07 | 240 | 115 | 10 | GO:0140013 |
| GeneOntologyBiologicalProcess | meiosis I | 1.71e-06 | 147 | 115 | 8 | GO:0007127 | |
| GeneOntologyBiologicalProcess | meiosis I cell cycle process | 2.54e-06 | 155 | 115 | 8 | GO:0061982 | |
| GeneOntologyBiologicalProcess | meiotic cell cycle | NCAPD3 EME1 HUS1 PIWIL2 PSMD13 FANCD2 ZSCAN21 WASHC5 MOV10L1 RAD54B RAD54L | 4.24e-06 | 350 | 115 | 11 | GO:0051321 |
| GeneOntologyBiologicalProcess | nuclear division | NCAPD3 EME1 PIWIL2 PSMD13 FANCD2 ZSCAN21 WASHC5 MOV10L1 RAD54B MAD2L2 CDCA5 RAD54L | 2.92e-05 | 512 | 115 | 12 | GO:0000280 |
| GeneOntologyBiologicalProcess | organelle fission | NCAPD3 EME1 PIWIL2 PSMD13 FANCD2 ZSCAN21 WASHC5 MOV10L1 RAD54B MAD2L2 CDCA5 RAD54L | 8.34e-05 | 571 | 115 | 12 | GO:0048285 |
| GeneOntologyBiologicalProcess | peptidyl-amino acid modification | STOX1 CDC42BPB CDK10 TTLL7 ULK3 SENP1 TTLL2 TREM2 MAP3K10 PRMT9 PKN2 DCLK2 GALNT6 MAD2L2 MAPK7 DCLK1 | 1.03e-04 | 976 | 115 | 16 | GO:0018193 |
| GeneOntologyBiologicalProcess | mitotic intra-S DNA damage checkpoint signaling | 1.08e-04 | 17 | 115 | 3 | GO:0031573 | |
| GeneOntologyBiologicalProcess | signal transduction in response to DNA damage | 1.31e-04 | 200 | 115 | 7 | GO:0042770 | |
| Domain | S_TKc | STK35 CDC42BPB CDK10 SCYL2 ULK3 MAP3K10 TAOK1 PKN2 DCLK2 MAPK7 MAP3K21 DCLK1 | 1.67e-06 | 359 | 112 | 12 | SM00220 |
| Domain | Protein_kinase_ATP_BS | STK35 CDC42BPB CDK10 ULK3 MST1R MAP3K10 TAOK1 PKN2 DCLK2 MAPK7 MAP3K21 DCLK1 | 2.92e-06 | 379 | 112 | 12 | IPR017441 |
| Domain | HEAT_REPEAT | 3.90e-06 | 70 | 112 | 6 | PS50077 | |
| Domain | ARM-like | PDS5B NCAPD3 RSPH14 IPO7 DOCK10 FRYL PPP4R4 SCYL2 SF3B1 UTP20 | 5.23e-06 | 270 | 112 | 10 | IPR011989 |
| Domain | ARM-type_fold | PDS5B NCAPD3 RSPH14 IPO7 DOCK11 FRYL PPP4R4 SCYL2 FOCAD SF3B1 UTP20 | 6.14e-06 | 339 | 112 | 11 | IPR016024 |
| Domain | Prot_kinase_dom | STK35 CDC42BPB CDK10 SCYL2 ULK3 MST1R MAP3K10 TAOK1 PKN2 DCLK2 MAPK7 MAP3K21 DCLK1 | 7.43e-06 | 489 | 112 | 13 | IPR000719 |
| Domain | - | 7.67e-06 | 222 | 112 | 9 | 1.25.10.10 | |
| Domain | PROTEIN_KINASE_DOM | STK35 CDC42BPB CDK10 SCYL2 ULK3 MST1R MAP3K10 TAOK1 PKN2 DCLK2 MAPK7 MAP3K21 DCLK1 | 8.11e-06 | 493 | 112 | 13 | PS50011 |
| Domain | Ser/Thr_kinase_AS | STK35 CDC42BPB CDK10 ULK3 MAP3K10 TAOK1 PKN2 DCLK2 MAPK7 MAP3K21 DCLK1 | 1.00e-05 | 357 | 112 | 11 | IPR008271 |
| Domain | PROTEIN_KINASE_ST | STK35 CDC42BPB CDK10 ULK3 MAP3K10 TAOK1 PKN2 DCLK2 MAPK7 MAP3K21 DCLK1 | 1.14e-05 | 362 | 112 | 11 | PS00108 |
| Domain | Pkinase | STK35 CDC42BPB CDK10 SCYL2 ULK3 MAP3K10 TAOK1 PKN2 DCLK2 MAPK7 DCLK1 | 1.83e-05 | 381 | 112 | 11 | PF00069 |
| Domain | PROTEIN_KINASE_ATP | STK35 CDC42BPB CDK10 ULK3 MST1R MAP3K10 TAOK1 PKN2 DCLK2 MAPK7 MAP3K21 DCLK1 | 2.01e-05 | 459 | 112 | 12 | PS00107 |
| Domain | Kinase-like_dom | STK35 CDC42BPB CDK10 SCYL2 ULK3 MST1R MAP3K10 TAOK1 PKN2 DCLK2 MAPK7 MAP3K21 DCLK1 | 2.21e-05 | 542 | 112 | 13 | IPR011009 |
| Domain | HEAT | 1.95e-04 | 48 | 112 | 4 | PF02985 | |
| Domain | Peptidase_S1C | 2.12e-04 | 4 | 112 | 2 | IPR001940 | |
| Domain | MLK1/MLK2/MLK4 | 2.12e-04 | 4 | 112 | 2 | IPR016231 | |
| Domain | MAP3K10 | 2.12e-04 | 4 | 112 | 2 | IPR015785 | |
| Domain | NUT | 3.52e-04 | 5 | 112 | 2 | IPR024310 | |
| Domain | NUT_N | 3.52e-04 | 5 | 112 | 2 | IPR024309 | |
| Domain | NUT | 3.52e-04 | 5 | 112 | 2 | PF12881 | |
| Domain | HEAT | 4.05e-04 | 58 | 112 | 4 | IPR000357 | |
| Domain | DUF3398 | 5.26e-04 | 6 | 112 | 2 | PF11878 | |
| Domain | DCX | 5.26e-04 | 6 | 112 | 2 | SM00537 | |
| Domain | DOCK_C/D_N | 5.26e-04 | 6 | 112 | 2 | IPR021816 | |
| Domain | - | 7.34e-04 | 7 | 112 | 2 | 3.10.20.230 | |
| Domain | DCX | 7.34e-04 | 7 | 112 | 2 | PF03607 | |
| Domain | SNF2_N | 9.17e-04 | 32 | 112 | 3 | IPR000330 | |
| Domain | SNF2_N | 9.17e-04 | 32 | 112 | 3 | PF00176 | |
| Domain | DC | 9.75e-04 | 8 | 112 | 2 | PS50309 | |
| Domain | Doublecortin_dom | 9.75e-04 | 8 | 112 | 2 | IPR003533 | |
| Domain | DOCK_C | 1.89e-03 | 11 | 112 | 2 | IPR010703 | |
| Domain | DHR-1_domain | 1.89e-03 | 11 | 112 | 2 | IPR027007 | |
| Domain | DHR_2 | 1.89e-03 | 11 | 112 | 2 | PS51651 | |
| Domain | DHR_1 | 1.89e-03 | 11 | 112 | 2 | PS51650 | |
| Domain | DOCK-C2 | 1.89e-03 | 11 | 112 | 2 | PF14429 | |
| Domain | DHR-2 | 1.89e-03 | 11 | 112 | 2 | IPR027357 | |
| Domain | DHR-2 | 1.89e-03 | 11 | 112 | 2 | PF06920 | |
| Domain | DOCK | 1.89e-03 | 11 | 112 | 2 | IPR026791 | |
| Domain | TTL | 2.66e-03 | 13 | 112 | 2 | PS51221 | |
| Domain | TTL/TTLL_fam | 2.66e-03 | 13 | 112 | 2 | IPR004344 | |
| Domain | TTL | 2.66e-03 | 13 | 112 | 2 | PF03133 | |
| Domain | SCAN | 4.62e-03 | 56 | 112 | 3 | SM00431 | |
| Domain | SCAN_BOX | 5.10e-03 | 58 | 112 | 3 | PS50804 | |
| Domain | SCAN | 5.10e-03 | 58 | 112 | 3 | PF02023 | |
| Domain | SCAN_dom | 5.10e-03 | 58 | 112 | 3 | IPR003309 | |
| Domain | IB | 5.12e-03 | 18 | 112 | 2 | SM00121 | |
| Domain | Retrov_capsid_C | 5.35e-03 | 59 | 112 | 3 | IPR008916 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | IPO7 HIP1R PSMD13 OLA1 PTBP1 SCYL2 FANCD2 SF3B1 NUP155 BRD4 TAOK1 PKN2 CNOT1 | 8.07e-08 | 582 | 116 | 13 | 20467437 |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | PDS5B NCAPD3 ZSCAN12 IPO7 DAG1 PTBP1 EPM2AIP1 SENP1 ZNF24 GANAB SF3B1 NUP155 WASHC5 RRN3 BRD4 MTX1 MGA CNOT1 | 1.01e-07 | 1203 | 116 | 18 | 29180619 |
| Pubmed | 6.71e-07 | 215 | 116 | 8 | 35973513 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | PDS5B DCHS2 DOCK11 PSMD13 TMEM87A SNX14 SHPRH CSTF2 TAOK1 CNOT1 ARHGAP21 | 9.27e-07 | 497 | 116 | 11 | 36774506 |
| Pubmed | PDS5B FRMPD4 SYNE1 DOCK10 MFAP3L EPM2AIP1 FOCAD GANAB ARHGAP21 VPS13B | 1.17e-06 | 407 | 116 | 10 | 12693553 | |
| Pubmed | FRMPD4 HIP1R DAG1 PSMD13 CORO1B NDUFA6 PTBP1 AQP4 CDC42BPB SF3B1 WASHC5 MAP3K10 DCLK2 MTX1 CNOT1 DCLK1 | 1.27e-06 | 1139 | 116 | 16 | 36417873 | |
| Pubmed | TRRAP is essential for regulating the accumulation of mutant and wild-type p53 in lymphoma. | 2.26e-06 | 28 | 116 | 4 | 29653964 | |
| Pubmed | NCAPD3 EME1 HUS1 PSMD13 FAAP100 EPM2AIP1 FANCD2 SF3B1 MAD2L2 MGA | 3.04e-06 | 453 | 116 | 10 | 29656893 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 5.49e-06 | 202 | 116 | 7 | 33005030 | |
| Pubmed | 5.68e-06 | 35 | 116 | 4 | 33864728 | ||
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 36094735 | ||
| Pubmed | Ginkgolic acid improves bleomycin-induced pulmonary fibrosis by inhibiting SMAD4 SUMOylation. | 1.10e-05 | 2 | 116 | 2 | 35707278 | |
| Pubmed | Doublecortin-like kinase enhances dendritic remodelling and negatively regulates synapse maturation. | 1.10e-05 | 2 | 116 | 2 | 23385585 | |
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 16650464 | ||
| Pubmed | m6A-driven SF3B1 translation control steers splicing to direct genome integrity and leukemogenesis. | 1.10e-05 | 2 | 116 | 2 | 36944332 | |
| Pubmed | Structural and functional analysis of the PDZ domains of human HtrA1 and HtrA3. | 1.10e-05 | 2 | 116 | 2 | 17962403 | |
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 31442435 | ||
| Pubmed | Distribution of the serine protease HtrA1 in normal human tissues. | 1.10e-05 | 2 | 116 | 2 | 14500695 | |
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 17417655 | ||
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 29099971 | ||
| Pubmed | Erk5 Is a Key Regulator of Naive-Primed Transition and Embryonic Stem Cell Identity. | 1.10e-05 | 2 | 116 | 2 | 27498864 | |
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 20167225 | ||
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 25729399 | ||
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 27358400 | ||
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 29557282 | ||
| Pubmed | Somatic hypermutation does not require Rad54 and Rad54B-mediated homologous recombination. | 1.10e-05 | 2 | 116 | 2 | 12548566 | |
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 18353795 | ||
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 12513693 | ||
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | PDS5B NCAPD3 TBC1D9B IPO7 HECTD3 DAG1 NDUFA6 FANCD2 GANAB NUP155 CSTF2 UTP20 MTX1 | 1.64e-05 | 942 | 116 | 13 | 31073040 |
| Pubmed | ZSCAN12 DOCK11 SYNE1 GRIK3 CORO1B CDC42BPB EPM2AIP1 SENP1 SF3B1 MGA CNOT1 ARHGAP21 DCLK1 | 2.06e-05 | 963 | 116 | 13 | 28671696 | |
| Pubmed | 2.32e-05 | 101 | 116 | 5 | 9872452 | ||
| Pubmed | RAD54 family translocases counter genotoxic effects of RAD51 in human tumor cells. | 3.30e-05 | 3 | 116 | 2 | 25765654 | |
| Pubmed | STAR syndrome-associated CDK10/Cyclin M regulates actin network architecture and ciliogenesis. | 3.30e-05 | 3 | 116 | 2 | 27104747 | |
| Pubmed | Roles of the DOCK-D family proteins in a mouse model of neuroinflammation. | 3.30e-05 | 3 | 116 | 2 | 32241915 | |
| Pubmed | Fanconi anemia FANCD2 and FANCI proteins regulate the nuclear dynamics of splicing factors. | 3.30e-05 | 3 | 116 | 2 | 29030393 | |
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 27655786 | ||
| Pubmed | Rad54/Rad54B deficiency is associated to increased chromosome breakage in mouse spermatocytes. | 3.30e-05 | 3 | 116 | 2 | 30204892 | |
| Pubmed | Changes in mRNA and protein levels of human HtrA1, HtrA2 and HtrA3 in ovarian cancer. | 3.30e-05 | 3 | 116 | 2 | 18241672 | |
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 17036055 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 14678011 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 26526391 | ||
| Pubmed | HtrA proteins as targets in therapy of cancer and other diseases. | 3.30e-05 | 3 | 116 | 2 | 20469960 | |
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 25002585 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 37257451 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 27481995 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 22307776 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 19061978 | ||
| Pubmed | The bromodomain protein Brd4 insulates chromatin from DNA damage signalling. | 3.30e-05 | 3 | 116 | 2 | 23728299 | |
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 28560410 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 20816174 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 22923201 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 32486357 | ||
| Pubmed | Alternative transcripts of Dclk1 and Dclk2 and their expression in doublecortin knockout mice. | 3.30e-05 | 3 | 116 | 2 | 18075264 | |
| Pubmed | 3.84e-05 | 486 | 116 | 9 | 20936779 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | PDS5B IPO7 SYNE1 OLA1 PTBP1 ZNF24 GANAB SF3B1 NUP155 CSTF2 UTP20 MGA CNOT1 | 3.88e-05 | 1024 | 116 | 13 | 24711643 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | PDS5B IPO7 HIP1R DOCK10 PSMD13 CORO1B PTBP1 POLR3A SF3B1 NUP155 WASHC5 UTP20 PKN2 MGA SORD | 4.54e-05 | 1353 | 116 | 15 | 29467282 |
| Pubmed | 6.10e-05 | 23 | 116 | 3 | 20301575 | ||
| Pubmed | Mutations of the Transcriptional Corepressor ZMYM2 Cause Syndromic Urinary Tract Malformations. | 6.45e-05 | 125 | 116 | 5 | 32891193 | |
| Pubmed | 6.59e-05 | 4 | 116 | 2 | 29266444 | ||
| Pubmed | 6.59e-05 | 4 | 116 | 2 | 25319828 | ||
| Pubmed | 6.59e-05 | 4 | 116 | 2 | 27500671 | ||
| Pubmed | Syntrophin-dependent expression and localization of Aquaporin-4 water channel protein. | 6.59e-05 | 4 | 116 | 2 | 11717465 | |
| Pubmed | Onset of aquaporin-4 expression in the developing mouse brain. | 6.59e-05 | 4 | 116 | 2 | 24915007 | |
| Pubmed | 6.59e-05 | 4 | 116 | 2 | 30590800 | ||
| Pubmed | 6.59e-05 | 4 | 116 | 2 | 33199366 | ||
| Pubmed | 6.59e-05 | 4 | 116 | 2 | 17456771 | ||
| Pubmed | 6.59e-05 | 4 | 116 | 2 | 16428451 | ||
| Pubmed | 6.59e-05 | 4 | 116 | 2 | 20534472 | ||
| Pubmed | 6.59e-05 | 4 | 116 | 2 | 12801647 | ||
| Pubmed | Expression of human HtrA1, HtrA2, HtrA3 and TGF-beta1 genes in primary endometrial cancer. | 6.59e-05 | 4 | 116 | 2 | 19424634 | |
| Pubmed | 6.59e-05 | 4 | 116 | 2 | 28642151 | ||
| Pubmed | NCAPD3 HECTD3 DOCK10 POLR3A FREM2 NUP155 WASHC5 RAD54B GALNT6 ARHGAP21 | 6.70e-05 | 650 | 116 | 10 | 38777146 | |
| Pubmed | PDS5B KDM3A NCAPD3 IPO7 OLA1 PTBP1 ALKBH5 ZNF24 ZSCAN21 BRD4 CDCA5 CNOT1 SORD | 8.23e-05 | 1103 | 116 | 13 | 34189442 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | TBC1D9B HIP1R FRYL CORO1B FAAP100 CDC42BPB FOCAD HIVEP3 MST1R ADAMTS7 BRD4 ARHGAP21 CYB5R2 | 8.38e-05 | 1105 | 116 | 13 | 35748872 |
| Pubmed | HTRA1 SYNE1 CORO1B NDUFA6 OLA1 PTBP1 AQP4 CDC42BPB SF3B1 WASHC5 NTM DCLK2 CNOT1 ARHGAP21 DCLK1 | 8.50e-05 | 1431 | 116 | 15 | 37142655 | |
| Pubmed | Gamma-radiation sensitivity and polymorphisms in RAD51L1 modulate glioma risk. | 9.97e-05 | 27 | 116 | 3 | 20610542 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | IPO7 HECTD3 FRYL PSMD13 CORO1B OLA1 PTBP1 FANCD2 SEC24D GANAB NUP155 WASHC5 CSTF2 CNOT1 SORD | 1.02e-04 | 1455 | 116 | 15 | 22863883 |
| Pubmed | 1.10e-04 | 5 | 116 | 2 | 34048572 | ||
| Pubmed | 1.10e-04 | 5 | 116 | 2 | 15710388 | ||
| Pubmed | 1.10e-04 | 5 | 116 | 2 | 15383666 | ||
| Pubmed | 1.10e-04 | 5 | 116 | 2 | 25446274 | ||
| Pubmed | Probing nuclear pore complex architecture with proximity-dependent biotinylation. | 1.32e-04 | 77 | 116 | 4 | 24927568 | |
| Pubmed | SHLD2/FAM35A co-operates with REV7 to coordinate DNA double-strand break repair pathway choice. | 1.52e-04 | 150 | 116 | 5 | 30154076 | |
| Pubmed | An evolutionarily conserved nested gene pair - Mab21 and Lrba/Nbea in metazoan. | 1.64e-04 | 6 | 116 | 2 | 19482073 | |
| Pubmed | The RhoGEF DOCK10 is essential for dendritic spine morphogenesis. | 1.64e-04 | 6 | 116 | 2 | 25851601 | |
| Pubmed | 1.64e-04 | 6 | 116 | 2 | 15837422 | ||
| Pubmed | 1.64e-04 | 6 | 116 | 2 | 16684769 | ||
| Pubmed | A role for Fkbp6 and the chaperone machinery in piRNA amplification and transposon silencing. | 1.64e-04 | 6 | 116 | 2 | 22902560 | |
| Pubmed | Expression of dystroglycan, fukutin and POMGnT1 during mouse cerebellar development. | 1.64e-04 | 6 | 116 | 2 | 12670716 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | PDC DOCK11 PIWIL2 STOX1 DSCAML1 FOCAD FREM2 CSTF2 UTP20 CNOT1 | 1.84e-04 | 736 | 116 | 10 | 29676528 |
| Pubmed | Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair. | 2.03e-04 | 357 | 116 | 7 | 37059091 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 2.09e-04 | 608 | 116 | 9 | 36089195 | |
| Pubmed | 2.11e-04 | 87 | 116 | 4 | 33798452 | ||
| Pubmed | Epidemiology of the antibiotic resistance of Helicobacter pylori in Canada. | 2.29e-04 | 7 | 116 | 2 | 11111111 | |
| Pubmed | DOCK11 PLEKHG7 DOCK10 PSMD13 ZNF24 GANAB CSTF2 ARHGAP8 MGA CDCA5 ARHGAP21 | 2.54e-04 | 916 | 116 | 11 | 32203420 | |
| Pubmed | Cell-Type-Specific Alternative Splicing Governs Cell Fate in the Developing Cerebral Cortex. | 2.59e-04 | 37 | 116 | 3 | 27565344 | |
| Pubmed | USP1 deubiquitinates Akt to inhibit PI3K-Akt-FoxO signaling in muscle during prolonged starvation. | 2.59e-04 | 37 | 116 | 3 | 32133736 | |
| Pubmed | 2.61e-04 | 494 | 116 | 8 | 26831064 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 2.75e-04 | 774 | 116 | 10 | 15302935 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | PDS5B NCAPD3 IPO7 SYNE1 PSMD13 OLA1 PTBP1 POLR3A FANCD2 GANAB SF3B1 NUP155 UTP20 CNOT1 | 2.89e-04 | 1425 | 116 | 14 | 30948266 |
| Interaction | C19orf38 interactions | 5.72e-07 | 86 | 114 | 7 | int:C19orf38 | |
| Interaction | BRCA1 interactions | NCAPD3 EME1 IPO7 HUS1 HECTD3 DAG1 PSMD13 OLA1 PTBP1 FAAP100 EPM2AIP1 FANCD2 GANAB SF3B1 NUP155 ZSCAN21 FAM161A BRD4 CSTF2 MAP3K21 CNOT1 ARHGAP21 | 1.67e-06 | 1249 | 114 | 22 | int:BRCA1 |
| Interaction | BTNL9 interactions | 2.96e-06 | 156 | 114 | 8 | int:BTNL9 | |
| Interaction | CDC42 interactions | PDS5B NCAPD3 DOCK11 SYNE1 DOCK10 DAG1 FRYL OLA1 CDC42BPB TMEM87A FANCD2 SENP1 GANAB NUP155 BRD4 MAP3K10 UTP20 TAOK1 PKN2 ARHGAP8 CNOT1 ARHGAP21 | 4.27e-06 | 1323 | 114 | 22 | int:CDC42 |
| Interaction | SCN2B interactions | 1.66e-05 | 95 | 114 | 6 | int:SCN2B | |
| Interaction | SMC1A interactions | PDS5B HIP1R FANCD2 MST1R GANAB SF3B1 BRD4 CSTF2 MAD2L2 MGA CDCA5 | 2.54e-05 | 418 | 114 | 11 | int:SMC1A |
| Interaction | RHOF interactions | PDS5B NCAPD3 IPO7 DOCK11 HIP1R DAG1 CDC42BPB SENP1 NUP155 UTP20 PKN2 MAD2L2 ARHGAP21 VPS13B | 2.69e-05 | 673 | 114 | 14 | int:RHOF |
| Interaction | NPTN interactions | 2.91e-05 | 278 | 114 | 9 | int:NPTN | |
| Interaction | STAG2 interactions | 4.12e-05 | 224 | 114 | 8 | int:STAG2 | |
| Interaction | CD70 interactions | 4.45e-05 | 166 | 114 | 7 | int:CD70 | |
| Interaction | GPR182 interactions | PDS5B NCAPD3 HIP1R TMEM87A FANCD2 FOCAD SNX14 WASHC5 SIMC1 UTP20 MTX1 | 5.49e-05 | 455 | 114 | 11 | int:GPR182 |
| Interaction | CDC37 interactions | HECTD3 PSMD13 STK35 CDK10 FANCD2 ULK3 MST1R BRD4 MAP3K10 DCLK2 MAPK7 MAP3K21 CDCA5 | 7.33e-05 | 645 | 114 | 13 | int:CDC37 |
| GeneFamily | Mitogen-activated protein kinase kinase kinases|RAF family | 1.06e-04 | 24 | 70 | 3 | 654 | |
| GeneFamily | Doublecortin superfamily | 6.52e-04 | 10 | 70 | 2 | 1369 | |
| GeneFamily | Tubulin tyrosine ligase family | 1.30e-03 | 14 | 70 | 2 | 779 | |
| GeneFamily | PDZ domain containing | 2.86e-03 | 152 | 70 | 4 | 1220 | |
| ToppCell | ASK440-Epithelial-Transformed_epithelium|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 5.99e-06 | 172 | 116 | 6 | df3800bcd9777d02900eba0cfc26ab73de8a1d95 | |
| ToppCell | AT1_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 7.53e-06 | 179 | 116 | 6 | 1603117b52623663458a977c94bf7f9f6c1114b8 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.53e-06 | 179 | 116 | 6 | 80112c686a8f85ad5e3cda6e3f3d3d51cf688092 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.77e-06 | 180 | 116 | 6 | 401df9cddcbca1eb8f0d2687bcacd98e95dc1493 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.77e-06 | 180 | 116 | 6 | f8a15c13d85c1bbbf86ce49bb6f86c368ddf22df | |
| ToppCell | Adult-Epithelial-ciliated_cell-D175|Adult / Lineage, Cell type, age group and donor | 9.09e-06 | 185 | 116 | 6 | 30f4980dee6cd5959655f8d74049f3bfb5312611 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 1.16e-05 | 193 | 116 | 6 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | facs-Trachea-3m|Trachea / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.30e-05 | 197 | 116 | 6 | e77016d64b1cac9825fec7cfe5071f1567401187 | |
| ToppCell | facs-Trachea-nan-3m|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-05 | 197 | 116 | 6 | 0353d925ee4b7aefc2c51b5fab873f465cdf9ebc | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Goblet|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.34e-05 | 198 | 116 | 6 | af07a970afaa435c6433bb5c1cbff4c67af350c7 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.41e-05 | 200 | 116 | 6 | 07d942803360e1a1e8e131d6e31c726dd0db1a0b | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.41e-05 | 200 | 116 | 6 | d0812817ef99608994193787a62d39adeb2070ca | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.41e-05 | 200 | 116 | 6 | cd54ddf1919c98e84b7e4aba85b374fc8b407206 | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_D|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.91e-05 | 125 | 116 | 5 | 9e98dcfdc768ae492f453efc08926164bbb0a909 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.90e-05 | 145 | 116 | 5 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | Healthy_donor-B_cell|World / disease group, cell group and cell class (v2) | 4.59e-05 | 150 | 116 | 5 | a2dfed562de7f58f902b547acec5a13853c80c4c | |
| ToppCell | NS-moderate-d_0-4-Myeloid-Monocyte-derived_DC|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.89e-05 | 152 | 116 | 5 | ce944f7c1444fd0cb793db183b96818e37342b24 | |
| ToppCell | Healthy_donor-B_cell|Healthy_donor / disease group, cell group and cell class (v2) | 4.89e-05 | 152 | 116 | 5 | 5768edfde8010324d8594815e73bbfba2c3045f3 | |
| ToppCell | TCGA-Thymus-Primary_Tumor-Thymoma-Type_C|TCGA-Thymus / Sample_Type by Project: Shred V9 | 6.81e-05 | 163 | 116 | 5 | 2dac87d15051151ccf193760ddd8b82534c3f922 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-A_(AT2)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 7.01e-05 | 164 | 116 | 5 | beaa13a75c3bb72446c85084d75e9fe3f15fd3d4 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c12-MKI67-TYROBP|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.01e-05 | 164 | 116 | 5 | 4ef776d1bab4103d42d3a4f22cdfb49e8d2bc5a0 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-A_(AT2)|343B / Donor, Lineage, Cell class and subclass (all cells) | 7.01e-05 | 164 | 116 | 5 | d005cfd821b87548b075120bffe65a0be9860463 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.07e-05 | 169 | 116 | 5 | e7514956b2e4298222ec443f98b2f5289451786e | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.07e-05 | 169 | 116 | 5 | 121768fc51fc3441ec725346a1bbe29e21d05971 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.77e-05 | 176 | 116 | 5 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | AT1_cells-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 9.77e-05 | 176 | 116 | 5 | 458720776b0151cd55acc352d509599cb62f0ca8 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-Mes-like-AT1_Progenitor|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.00e-04 | 177 | 116 | 5 | 164ffbbf798defa3728197deb1a14b661490e525 | |
| ToppCell | facs-Lung-3m-Epithelial-airway_epithelial-respiratory_basal_cell-basal_epithelial_cell_of_bronchioalveolar_tree|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.03e-04 | 178 | 116 | 5 | b89c4d015b44bf538aa39969ef8778877c8023f1 | |
| ToppCell | 343B-Lymphocytic-NK_cells-Proliferating_NK_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.03e-04 | 178 | 116 | 5 | c7e890cd02206c516cf1d7692ea7abc8ce746482 | |
| ToppCell | facs-Lung-3m-Epithelial-airway_epithelial-respiratory_basal_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.03e-04 | 178 | 116 | 5 | fb8f8d95f6b08378fb42c4076ee040276faa296f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.11e-04 | 181 | 116 | 5 | 5f2d3a08577c440c944778d07aa993c6e7873f3d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.11e-04 | 181 | 116 | 5 | c7c5f7d4c397b4613c772413a0a679377efffff3 | |
| ToppCell | 343B-Lymphocytic-NK_cells-Proliferating_NK_cell|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.14e-04 | 182 | 116 | 5 | b1e66ccd5f33b4801f1cafddf97f5fc0c6dba8d1 | |
| ToppCell | BAL-Control-Myeloid-Macrophage|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.17e-04 | 183 | 116 | 5 | 8e9d45c96b44558158e3d59613f64a73d5390c19 | |
| ToppCell | BAL-Control-Myeloid-Macrophage-transitional_Macro-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.17e-04 | 183 | 116 | 5 | 0408d991ddb639594b45d5cb2432dd29289167b1 | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-5|TCGA-Liver / Sample_Type by Project: Shred V9 | 1.17e-04 | 183 | 116 | 5 | f604a8b62c7088fad8365dbf8d910fc980bd3ba8 | |
| ToppCell | COPD-Epithelial-ATII|World / Disease state, Lineage and Cell class | 1.17e-04 | 183 | 116 | 5 | 8e9aab4eeec2e282c2cab9bfca6dbf40d660c7b9 | |
| ToppCell | BAL-Control-Myeloid-Macrophage-transitional_Macro|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.17e-04 | 183 | 116 | 5 | 79f05b8a967124d831b0baef137e30659f5917a7 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-04 | 184 | 116 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | BAL-Control-Myeloid-Macrophage-transitional_Macro-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.20e-04 | 184 | 116 | 5 | 92202e1cd0bba1ce4b061ebcb8a2af5bb590542a | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-04 | 184 | 116 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | Control-Neu_4|World / 5 Neutrophil clusters in COVID-19 patients | 1.20e-04 | 184 | 116 | 5 | ce7f044956613118ee2e9fb6af2455c3166cb414 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-04 | 184 | 116 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | BAL-Control-Myeloid-Macrophage|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.20e-04 | 184 | 116 | 5 | 7331535d469453a5264dcb0270a97f63d3b55201 | |
| ToppCell | BAL-Control-Myeloid-Macrophage-transitional_Macro|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.20e-04 | 184 | 116 | 5 | 337e38a6b2b6770cc992d88b006829f194841b10 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Undifferentiated_Pleomorphic_Sarcoma|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 1.33e-04 | 188 | 116 | 5 | 3df5a5b645403914c4d0506e2d93f8a8a98e3fa6 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D231|Adult / Lineage, Cell type, age group and donor | 1.36e-04 | 189 | 116 | 5 | 5a04cb25f8f0447b2cecdb6c3695029281aca26d | |
| ToppCell | Control-Myeloid-transitional_Macro|Control / Disease group,lineage and cell class (2021.01.30) | 1.43e-04 | 191 | 116 | 5 | 3ed0b1ff628a165e3c92c2e493206015f57dccfe | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.43e-04 | 191 | 116 | 5 | 34cc997e4e5c727495f321e6807a84aa124da486 | |
| ToppCell | Control-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 1.47e-04 | 192 | 116 | 5 | 1bfd022d5b87cf8a5d5069f559339a553a52a0a2 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.50e-04 | 193 | 116 | 5 | fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.50e-04 | 193 | 116 | 5 | bdb7401dd9059032f930f2b575f2ef8e504b6594 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.50e-04 | 193 | 116 | 5 | f3cc7cfdbc164a4ed42f87647111522b7d393bcb | |
| ToppCell | NS-critical-d_07-13-Epithelial-Secretory|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.54e-04 | 194 | 116 | 5 | 2172d951896265243d14996eacce5aab5e14e26e | |
| ToppCell | wk_20-22-Epithelial-Distal_epithelial-type_II_pneumocyte|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.58e-04 | 195 | 116 | 5 | 45d1acd316d0ced97dfb150c3a943128d8fa4e7e | |
| ToppCell | wk_15-18-Epithelial-Distal_epithelial-type_II_pneumocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.58e-04 | 195 | 116 | 5 | 0e3aac1b1a1fd483f5fb9a394eb90c0e1ce63542 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.62e-04 | 196 | 116 | 5 | 7e5addaa844e66f8160e05858c341866a80aed23 | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-04 | 196 | 116 | 5 | 2029f58ce6a7b8c35d3a7496c3341391990909ce | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-04 | 196 | 116 | 5 | 151f1a29a91f8b234e9b6ed062666357a2f69128 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.62e-04 | 196 | 116 | 5 | 545d2e4469924d333e3f655f559c899fa1260196 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Basal_3|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.66e-04 | 197 | 116 | 5 | 4f8f23b1ef2eae9d300bd2c1a5cb7ef0163858a1 | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX-Basal_3|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.66e-04 | 197 | 116 | 5 | 2cff37f9d33951840a8f52ccbba6ca1a4bbe3ad9 | |
| ToppCell | Mild-Lymphoid-T-Proliferating_T|Mild / Condition, Lineage, Cell class and cell subclass | 1.66e-04 | 197 | 116 | 5 | 794517c70089da109f4c6489fe406c0ba6882b76 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.66e-04 | 197 | 116 | 5 | bf10727fbe90b71d2ac60a11711e5f0701b3799d | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Basal_3-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.66e-04 | 197 | 116 | 5 | 0f37afad46b94c748a149d9ee681472d7a3e6937 | |
| ToppCell | COVID-19_Moderate-T/NK_proliferative|COVID-19_Moderate / disease group, cell group and cell class | 1.69e-04 | 198 | 116 | 5 | 166c000fb0e19602ffdd8bf2b2f19be2c6df96a6 | |
| ToppCell | COVID-19_Moderate-T/NK_proliferative|World / disease group, cell group and cell class | 1.69e-04 | 198 | 116 | 5 | bf0131fbca6032e1aab4aa807f8c1d3be689cb7f | |
| ToppCell | facs-Tongue-nan-3m-Epithelial-basal_cell_of_epidermis|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-04 | 198 | 116 | 5 | 22559b161e67b49fe8028bfaf861e069063599f5 | |
| ToppCell | distal-Hematologic-Proliferating_Macrophage-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.69e-04 | 198 | 116 | 5 | 8afeb1f9bc9d8551482c8fefe4c5f88d9cd13ee2 | |
| ToppCell | distal-Hematologic-Proliferating_Macrophage-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.69e-04 | 198 | 116 | 5 | 2b0716e900bce54ad1825d6dcdaf4ebf31f355c4 | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma|TCGA-Bladder / Sample_Type by Project: Shred V9 | 1.69e-04 | 198 | 116 | 5 | 65875fbd99393cdd62595c713ab90db06d28081f | |
| ToppCell | TCGA-Ovary-Primary_Tumor|TCGA-Ovary / Sample_Type by Project: Shred V9 | 1.70e-04 | 106 | 116 | 4 | 14f548be39cec604fbdae0382cbf434fa4049840 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma|TCGA-Ovary / Sample_Type by Project: Shred V9 | 1.70e-04 | 106 | 116 | 4 | 939b80950d39cdc7149a05fdfb64c8810064cdb1 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma|TCGA-Ovary / Sample_Type by Project: Shred V9 | 1.70e-04 | 106 | 116 | 4 | e9e1b55f32b3d5b9eeec94a997912e5c21c1fb48 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2_proliferating-AT2_proliferating_L.0.1.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.73e-04 | 199 | 116 | 5 | d7dbc551c05da32c698908348572fb0ce1166e10 | |
| ToppCell | facs-Tongue-nan-3m-Epithelial-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.73e-04 | 199 | 116 | 5 | 8d50e1ee58710d896c0204937331d9f4dcd38de0 | |
| ToppCell | Biopsy_Other_PF-Epithelial-AT2|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.73e-04 | 199 | 116 | 5 | 9a65acfe9bf500db72142469cf17bf0973540001 | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-Proliferating_Epithelial_cells|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 1.73e-04 | 199 | 116 | 5 | 4fcf5bec207e4384fd73c5e8801a7e414e3ee7b0 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2_proliferating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.73e-04 | 199 | 116 | 5 | 6a89c3a65fa50af92585c52bec203bcff6f94efc | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.73e-04 | 199 | 116 | 5 | 1d5a3366474c17e3df0ba5cf11b586655529e9bd | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.73e-04 | 199 | 116 | 5 | 2dc33804f6691d7c9682e6c9b885e945fb97fc36 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-FOXM1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.73e-04 | 199 | 116 | 5 | be2276c9a1994579ba1d2998b49bf549c1324d44 | |
| ToppCell | Mild-T/NK_proliferative|Mild / Disease group and Cell class | 1.73e-04 | 199 | 116 | 5 | 64a5c91243ee999ea21ffddd450d3e5fdbf6470b | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW13-Stem_cells|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 1.78e-04 | 200 | 116 | 5 | d933978b55fefe52cad599b36f6b47a0c7f71f96 | |
| ToppCell | distal-Hematologic-Proliferating_Macrophage|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.78e-04 | 200 | 116 | 5 | 3835a8a9739b8cd5bf19c40765ef76907ac1ad38 | |
| ToppCell | Biopsy_IPF-Epithelial-Proliferating_Epithelial_cells|Biopsy_IPF / Sample group, Lineage and Cell type | 1.78e-04 | 200 | 116 | 5 | 63c5402f050fdb12abab3c8b7f33d4914ae26b9b | |
| ToppCell | Hematolymphoid-Microglia-TYROBP----L1-3|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.78e-04 | 200 | 116 | 5 | a20dce14f94777687aad57d6fbe3258ad376f63f | |
| ToppCell | Lung_Parenchyma-Control-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.78e-04 | 200 | 116 | 5 | c2bde99b3bc7a8740441c1a0c1394892b940b857 | |
| ToppCell | Hematolymphoid-Microglia-TYROBP--|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.78e-04 | 200 | 116 | 5 | dc344b3ec51d506952e38f0b3a7795d65f9dd4eb | |
| ToppCell | Parenchymal-10x3prime_v2-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.78e-04 | 200 | 116 | 5 | a8b59e6fe04271fef61db911a286b5c48438bb84 | |
| ToppCell | Hematolymphoid-Microglia-TYROBP-|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.78e-04 | 200 | 116 | 5 | 3bba5219453322198e8fdb0921d5f8c403598751 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.78e-04 | 200 | 116 | 5 | 3ff9abd5e07780a59d5571da906fa15f00a1d5c2 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW13-Stem_cells-Neuroepithelial_cell|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 1.78e-04 | 200 | 116 | 5 | 3d932765c31aef1f80a118d51e8e66c50a758dbb | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Macroglial|6m / Sample Type, Dataset, Time_group, and Cell type. | 1.78e-04 | 200 | 116 | 5 | 42dc8ed66a021097e703eef2d756607396ca2f56 | |
| ToppCell | distal-Hematologic-Proliferating_Macrophage-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.78e-04 | 200 | 116 | 5 | 9c03a8da12d29618f72c429836c1d1bd84a78b12 | |
| ToppCell | Hematolymphoid-Microglia|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.78e-04 | 200 | 116 | 5 | 21bcca3b670fe9bac034aef2275d3de4a9a73e2b | |
| ToppCell | Biopsy_Other_PF-Immune-Proliferating_Macrophages|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.78e-04 | 200 | 116 | 5 | 61473e8613f39a92002d5b631e6bd563735566e4 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.78e-04 | 200 | 116 | 5 | af3dc76b4507bf4edd265169f5dfbbb8a19eb394 | |
| ToppCell | Hematolymphoid-Microglia-TYROBP---|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.78e-04 | 200 | 116 | 5 | a8646d0fca99f10827c2d2a12e584660ef7155f1 | |
| ToppCell | Hematolymphoid-Microglia-TYROBP|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.78e-04 | 200 | 116 | 5 | 33036d21c1c82109284473a515c4f890b33fdd5c | |
| Disease | dyslexia (implicated_via_orthology) | 1.40e-05 | 2 | 111 | 2 | DOID:4428 (implicated_via_orthology) | |
| Disease | Lymphoma, non-Hodgkin, familial | 1.39e-04 | 5 | 111 | 2 | cv:C4721532 | |
| Disease | Cerebellar Ataxia | 1.39e-04 | 5 | 111 | 2 | C0007758 | |
| Disease | Non-Hodgkin lymphoma | 1.39e-04 | 5 | 111 | 2 | cv:C0024305 | |
| Disease | LYMPHOMA, NON-HODGKIN, FAMILIAL | 1.39e-04 | 5 | 111 | 2 | 605027 | |
| Disease | Polycystic kidney disease, type 2 | 2.91e-04 | 7 | 111 | 2 | C2751306 | |
| Disease | colon cancer (is_implicated_in) | 3.38e-04 | 36 | 111 | 3 | DOID:219 (is_implicated_in) | |
| Disease | muscular dystrophy-dystroglycanopathy type B1 (implicated_via_orthology) | 3.87e-04 | 8 | 111 | 2 | DOID:0050588 (implicated_via_orthology) | |
| Disease | Polycystic Kidney, Type 1 Autosomal Dominant Disease | 3.87e-04 | 8 | 111 | 2 | C0887850 | |
| Disease | Polycystic Kidney, Autosomal Dominant | 4.96e-04 | 9 | 111 | 2 | C0085413 | |
| Disease | MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2K | 1.24e-03 | 14 | 111 | 2 | C1836373 | |
| Disease | alpha-Dystroglycanopathies | 1.24e-03 | 14 | 111 | 2 | C2936406 | |
| Disease | Muscle eye brain disease | 1.24e-03 | 14 | 111 | 2 | C0457133 | |
| Disease | Fukuyama Type Congenital Muscular Dystrophy | 1.24e-03 | 14 | 111 | 2 | C0410174 | |
| Disease | Muscular Dystrophy-Dystroglycanopathy (Congenital with Brain and Eye Anomalies) Type A, 1 | 1.24e-03 | 14 | 111 | 2 | C4284790 | |
| Disease | Walker-Warburg congenital muscular dystrophy | 1.43e-03 | 15 | 111 | 2 | C0265221 | |
| Disease | Intellectual Disability | 1.54e-03 | 447 | 111 | 7 | C3714756 | |
| Disease | urolithiasis | 1.75e-03 | 63 | 111 | 3 | MONDO_0024647 | |
| Disease | non-Hodgkin lymphoma (is_implicated_in) | 1.84e-03 | 17 | 111 | 2 | DOID:0060060 (is_implicated_in) | |
| Disease | Dementia | 1.84e-03 | 17 | 111 | 2 | C0497327 | |
| Disease | muscular dystrophy (is_implicated_in) | 1.84e-03 | 17 | 111 | 2 | DOID:9884 (is_implicated_in) | |
| Disease | low density lipoprotein cholesterol measurement, body fat percentage | 1.84e-03 | 17 | 111 | 2 | EFO_0004611, EFO_0007800 | |
| Disease | Alzheimer disease, brain volume measurement | 1.84e-03 | 17 | 111 | 2 | EFO_0006930, MONDO_0004975 | |
| Disease | parahippocampal gyrus volume measurement | 2.06e-03 | 18 | 111 | 2 | EFO_0010318 | |
| Disease | MYELODYSPLASTIC SYNDROME | 2.08e-03 | 67 | 111 | 3 | C3463824 | |
| Disease | Alopecia | 2.30e-03 | 19 | 111 | 2 | C0002170 | |
| Disease | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement | 2.59e-03 | 364 | 111 | 6 | EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946 | |
| Disease | Low Grade Lymphoma (neoplasm) | 2.81e-03 | 21 | 111 | 2 | C0079747 | |
| Disease | Lymphoma, Intermediate-Grade | 2.81e-03 | 21 | 111 | 2 | C0079741 | |
| Disease | High Grade Lymphoma (neoplasm) | 2.81e-03 | 21 | 111 | 2 | C0079740 | |
| Disease | Diffuse Mixed-Cell Lymphoma | 2.81e-03 | 21 | 111 | 2 | C0079757 | |
| Disease | Lymphoma, Undifferentiated | 2.81e-03 | 21 | 111 | 2 | C0024306 | |
| Disease | Reticulosarcoma | 2.81e-03 | 21 | 111 | 2 | C0024302 | |
| Disease | Lymphoma, Mixed-Cell | 2.81e-03 | 21 | 111 | 2 | C0024304 | |
| Disease | Lymphoma, Diffuse | 2.81e-03 | 21 | 111 | 2 | C3714542 | |
| Disease | Lymphoma, Non-Hodgkin, Familial | 3.08e-03 | 22 | 111 | 2 | C4721532 | |
| Disease | Lymphoma, Small Noncleaved-Cell | 3.08e-03 | 22 | 111 | 2 | C0079770 | |
| Disease | Hepatitis | 3.08e-03 | 22 | 111 | 2 | HP_0012115 | |
| Disease | Nasopharyngeal carcinoma | 3.08e-03 | 22 | 111 | 2 | C2931822 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HRIIKETQRLLAEPV | 6 | Q5JXB2 | |
| DLILKPGVVHVIDVD | 291 | P55087 | |
| KPIVLKRIVAHAVEV | 56 | Q96FF9 | |
| IPKHIPERVSLVVTE | 241 | Q6P2P2 | |
| PLVVVKEEKIHSPII | 1106 | O60885 | |
| LVIQKLVEHRVIPEG | 171 | Q6P6C2 | |
| PEVADKIVLVADRHL | 2321 | Q8IYW2 | |
| LTEPVVVLEGHTKRV | 121 | Q9BR76 | |
| TVPLLHAAIREVDIK | 281 | Q00796 | |
| IVDPEIALKILHRQT | 181 | P33240 | |
| PIHITIVRLVLLEDE | 286 | Q9UKP4 | |
| LAVIHELRPTEKVVL | 651 | Q9Y620 | |
| IKFLLERIAPVHIDT | 601 | Q9NTI5 | |
| ILVRKELEEIARTHP | 191 | Q6BCY4 | |
| VHVVVDPILSKVLRP | 141 | Q92698 | |
| VAVDVAVPKRLLEIV | 26 | Q6PII5 | |
| PIRDIEIIHEELQLK | 141 | Q9NTK5 | |
| ELRALSHVLKTPIEV | 221 | Q7L8S5 | |
| VVVILVHGELRIETK | 16 | P32926 | |
| HDNIIAIKDILRPTV | 111 | Q13164 | |
| VPIIHRDLKSINILI | 216 | Q02779 | |
| VPVIIARTDHIIVKE | 46 | O75121 | |
| IHLGVKVLFPEEIIL | 651 | Q9BXT6 | |
| EKVVVVILDKEHRPV | 81 | Q9UI95 | |
| VHATIVSEKLLDPRI | 111 | Q13021 | |
| LPRLHLVPAEKAVEV | 201 | Q8IWI9 | |
| SRVHLIVQVSPKIVE | 126 | Q9P121 | |
| HSVEKTVLIIVIPVD | 1286 | Q5SZK8 | |
| EVSILRRVKHPNIVL | 436 | O15075 | |
| LIENEVSILRRVKHP | 436 | Q8N568 | |
| LHTVIPAVVVAAILL | 751 | Q14118 | |
| LLPEREVHVLEHTKI | 226 | P20941 | |
| VEAIIHSPELIRVQL | 96 | O95373 | |
| TEHPKLLRVLSVEAI | 756 | Q6ZU69 | |
| TEHPKLLRVLSVEAI | 486 | Q63HN1 | |
| IHKLFAPVRISITLV | 156 | Q96KR6 | |
| LIEELHPIIKEALER | 951 | O94915 | |
| AHVTDPRVVDLLVIK | 71 | P56556 | |
| VNPLSLVEIILHVVR | 71 | Q9UNM6 | |
| VHQIELAPREKIVIL | 1281 | Q9Y5S2 | |
| LVKILHHLEEPVIFI | 271 | Q0VG06 | |
| VRHLLVLATPVDIVI | 161 | O75694 | |
| LLVLTVVIEKREHSP | 1066 | Q6V1P9 | |
| HLLARAVALLVIPVV | 261 | Q9Y6A1 | |
| RASALAEHIKPVVVI | 291 | O75146 | |
| VVEKIAPAVVHIELF | 146 | P83110 | |
| VEKIAPAVVHIELFR | 176 | Q92743 | |
| LKIVDPSLIHVEVVH | 231 | Q9Y4C1 | |
| PHSEIVLVAKIEKVL | 501 | Q96BY6 | |
| PHPEIFLVARIEKVL | 471 | Q5JSL3 | |
| LRLRHPNIVELKEVV | 91 | Q15131 | |
| HIDIPRVQLLIEDKE | 1656 | Q8TD84 | |
| EVLLREVLPEHVSVL | 126 | Q7L775 | |
| ESAEVHLIKERPLVI | 251 | Q53HC0 | |
| RVELHVLDVKPITLL | 481 | Q14CM0 | |
| LHTTPAILLKEIILV | 201 | Q8NCL4 | |
| IPINREILEEVTKHT | 251 | Q8IY85 | |
| EECLKHIIVVLDPVL | 246 | Q96AY2 | |
| LHLKEVQPVVIREDS | 121 | Q3B820 | |
| VAPLTITHVREKAID | 516 | Q13003 | |
| EHTILHLPEKIRPEI | 721 | Q5VW36 | |
| EDLPVIIKFILHSVT | 276 | Q9BXW9 | |
| ILVRIPGEIIVAHIE | 1561 | Q3ZCN5 | |
| VHLKRLLIVVVVVVL | 31 | P11686 | |
| EVISVPHKIITHLRK | 211 | Q13505 | |
| KVEAVIHPRFLEELL | 456 | A1L443 | |
| KVEAVIHPRFLEELL | 441 | Q5VZR2 | |
| IHITKPVHILEERSL | 31 | Q8N807 | |
| FPTLRHEILELIIEK | 236 | Q9NYV6 | |
| ESSELLHLVPVERVK | 576 | O75691 | |
| LHLVPVERVKNLVLT | 581 | O75691 | |
| IEVLPKETLRHEILN | 161 | Q6NUP7 | |
| VIHAIRPELVDLETV | 216 | Q8NF91 | |
| PVHVAFERLELKELI | 116 | Q5TCX8 | |
| PLVLTVEHKEKELIV | 201 | Q8TC59 | |
| VHLIHEVTKVLLVLE | 76 | Q14697 | |
| SRIVTHDIPIKVIPR | 126 | O60921 | |
| RIDEVAVPVHVAKIL | 376 | O14802 | |
| VELHLRVPLEKEIPV | 386 | Q9P0U3 | |
| PPREIVAHIIQKILL | 501 | Q8NDZ2 | |
| LTIIEATHVLLVEPI | 1591 | Q149N8 | |
| PTIVHRFLIKATIEE | 1626 | Q149N8 | |
| IPEEVREHVKLLLNV | 296 | Q6P3W7 | |
| LKHIFVLRERPETVL | 276 | Q7L7X3 | |
| HPKSRIIIEELSLVA | 286 | Q16513 | |
| ILVPVSIGIVIKHRI | 281 | Q5PT55 | |
| HSIIPLAVVLTLIVI | 1396 | Q13018 | |
| AVLHQPLKVIREILV | 796 | O94855 | |
| HLIIPLREVTIVEKA | 341 | Q66K14 | |
| IAIKQTPELTLHEIV | 31 | O15204 | |
| KESIFPVVRILLQHI | 346 | P42695 | |
| VQELVHPVVDRSIKI | 1401 | A5YKK6 | |
| IVHRDLKPDNILITE | 356 | Q8TDR2 | |
| LRPETHTKEQILELV | 81 | P17028 | |
| IIKLQTHDIIEVPTR | 641 | Q12768 | |
| PEIHTKEQILELLVL | 76 | Q9Y5A6 | |
| VLIRRIHKVDIPSII | 176 | Q9Y5W7 | |
| DVIPILVHLLKDPVE | 231 | Q9UHP6 | |
| LVVTLPHKVEDERVL | 656 | Q96N76 | |
| VHKILVVIEPLLIDE | 571 | O75533 | |
| DVEHEIIKRINPILT | 356 | Q6ZVD7 | |
| IEVPHKLLERVTFVD | 176 | Q86TD4 | |
| VVLPKHILDIWVIVL | 11 | Q9BZL3 | |
| VPRTQVIEHITKLIT | 456 | Q5T1R4 | |
| VLVKRKLVHDIIDLI | 401 | Q9BWV7 | |
| LRKVLVEVLADPLDH | 121 | Q9NZC2 | |
| DIHIPAVILKTFLRE | 291 | P85298 | |
| IRILVDKINLEHSVP | 691 | Q7Z7G8 | |
| RLVVKSIEPLHVSVF | 611 | Q6ZR37 | |
| LRPEVHTKEQILELL | 81 | Q96N95 | |
| LRLHQLVETVELKIP | 266 | Q9UHV5 | |
| IVVISLLTKPIPDVH | 541 | P13866 | |
| VRTVIVPSEKVVDLL | 271 | Q5T5U3 | |
| VPSRVIHIRKLPIDV | 56 | P26599 | |
| IHIRKLPIDVTEGEV | 61 | P26599 | |
| RPETHTKEQILELLV | 76 | O43309 | |
| LLAEVKDVLIPHERV | 1066 | Q04912 | |
| SELVVKTLIVAEPHV | 296 | Q6ZT98 | |
| IVKPRLGVTLHKVVV | 321 | Q8NBN3 | |
| TEIEILKGIRHPHIV | 61 | Q6PHR2 | |
| DMTVHLPIIEIRIVE | 341 | Q5T447 |